ArticleCureus2026
Complementary Vaccination in Morocco's Pediatric Population: A Cross-Sectional Study at Mohamed VI University Hospital, Oujda.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionComplementary vaccination (CV) in Morocco refers to vaccines administered in addition to those in the National Immunization Program (NIP). Although optional, CV plays a crucial role in preventing certain childhood diseases. This study aimed to determine the CV rate and identify factors associated with reluctance to receive CV. MATERIAL/
methodsA cross-sectional study employing descriptive and analytical methods was conducted among a sample of 450 mothers of children aged one to 16 years at the University Hospital Mohammed VI in Oujda, Morocco, over four months.
resultsAll children were vaccinated according to the NIP. Most children (414; 92%) had received their obligatory vaccinations at health centers, while only 36 (8%) had received them at a private pediatrician. Only 85 children (19%) had received complementary vaccines (CVs). The hepatitis A vaccine was the most noted (89%). Mothers' knowledge of CVs is limited. Information on the names of CVs, the age of vaccine administration, the number of doses, and the benefit of the vaccine was limited among 369 mothers (82%). Mothers are often reluctant to accept CV because of a lack of knowledge about the vaccine among 351 mothers (78%), fears about vaccine safety among 279 mothers (62%), the unimportance of the vaccine among 256 mothers (57%), the non-obligatory nature of the vaccine among 234 mothers (52%), the sufficiency of compulsory NIP vaccines among 225 mothers (50%), the non-availability of the vaccine at the health center among 220 mothers (49%) and the high cost of the vaccine among 202 mothers (45%). Statistical analysis showed that multiparity (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.